Multiclonal epidemic of Klebsiella pneumoniae isolates producing DHA-1 in a Spanish hospital

Clinical Microbiology and Infection

Volumn 17, Issue 7, 2011, Pages 1032-1036

  Diestra, K ^a,b   Miro E ^a   Marti C ^c   Navarro, D ^c   Cuquet, J ^c,d   Coll, P ^a,b   Navarro, F ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL GENERAL DE GRANOLLERS   (Spain)

^d Equip de Control de la Infecció Nosocomial de l'Hospital General de Granollers ^*  (Spain)

Author keywords

AmpC; Epidemiology; ESBL; Multilocus sequence typing; Resistance mechanisms

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; DHA 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; EPIDEMIC; FEMALE; HUMAN; INFANT; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTILOCUS SEQUENCE TYPING; NEWBORN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPAIN;

KLEBSIELLA PNEUMONIAE;

EID: 79959924632     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03319.x     Document Type: Article

References (22)

1. Jacoby GA. AmpC β-lactamases. Clin Microbiol Rev 2009; 22: 161-182.
2. Woodford N, Reddy S, Fagan E et al. Wide geographic spread of diverse acquired AmpC β-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J Antimicrob Chemother 2007; 59: 102-105.
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement. M100-S17. Wayne, PA: CLSI, 2007.
4. Aragón L, Mirelis B, Miró E et al. Increase in β-lactam-resistant Proteus mirabilis strains due to CTX-M and CMY-type as well as new VEB- and inhibitor-resistant TEM-type β-lactamases. J Antimicrob Chemother 2008; 61: 1029-1032.
5. Seo M, Park Y, Pai H. Characteristics of plasmid-mediated quinolone resistance genes in extended-spectrum cephalosporin-resistant isolates of Klebsiella pneumoniae and Escherichia coli in Korea. Chemotherapy 2010; 56: 46-53.
6. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 2009; 53: 2227-2238.
7. Cuzon G, Naas T, Guibert M, Nordmann P. In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum β-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase. Int J Antimicrob Agents 2010; 35: 265-268.
8. Samuelsen O, Naseer U, Tofteland S et al. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. J Antimicrob Chemother 2009; 63: 654-658.
9. Diancourt L, Passet V, Verhoef J, Grimont PAD, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43: 4178-4182.
10. Vimont S, Mnif B, Fevre C, Brisse S. Comparison of PFGE and multilocus sequence typing for analysis of Klebsiella pneumoniae isolates. J Med Microbiol 2008; 57: 1308-1310.
11. Ko K, Yeom J, Lee M, Peck K, Song J. Clonal dissemination of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae isolates in a Korean hospital. J Korean Med Sci 2008; 23: 53-60.
12. Oteo J, Cuevas O, López-Rodríguez I et al. Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults. J Antimicrob Chemother 2009; 64: 524-528.
13. Coelho A, Mirelis B, Alonso-Tarrés C et al. Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain. J Antimicrob Chemother 2009; 64: 862-864.
14. Carattoli A, Miriagou V, Bertini A et al. Replicon typing of plasmids encoding resistance to newer β-lactams. Emerg Infect Dis 2006; 12: 1145-1148.
15. CTX-M-9 gene in non-related Escherichia coli from Barcelona. J Antimicrob Chemother 2005; 56: 819-826.
16. Bou G, Oliver A, Ojeda M, Monzon C, Martinez-Beltran J. Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in Spain. Antimicrob Agents Chemother 2000; 44: 2549-2553.
17. Mata C, Miro E, Rivera A, Mirelis B, Coll P, Navarro F. Prevalence of acquired AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clin Microbiol Infect 2010; 16: 472-476.
18. Mirelis B, Rivera A, Miró E, Mesa R, Navarro F, Coll P. A simple phenotypic method for differentiation between acquired and chromosomal AmpC β-lactamases in Escherichia coli. Enferm Infecc Microbiol Clin 2006; 24: 370-372.
19. Navarro F, Perez-Trallero E, Marimon J, Aliaga R, Gomariz M, Mirelis B. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). J Antimicrob Chemother 2001; 48: 383-389.
20. Conejo C, Mata C, Navarro F, Pascual A. Detection and reporting β-lactam resistance phenotypes in Escherichia coli and Klebsiella pneumoniae: a multicenter proficiency study in Spain. Diagn Microbiol Infect Dis 2008; 62: 317-325.
21. Philippon A, Arlet G, Jacoby G. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002; 46: 1-11.
22. Kyoung H, Young U, Kim J, Kim H, Shin D, Song W. First outbreak of multidrug-resistant Klebsiella pneumoniae producing both SHV-12-type extended-spectrum β-lactamase and DHA-1-type AmpC β-lactamase at a Korean hospital. Yonsei Med J 2008; 49: 53-57.